Literature DB >> 2552799

Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes.

S V Pizzo1.   

Abstract

Antithrombin III (ATIII) clearance from blood occurs by redistribution into the extravascular compartment and by binding to the endothelial surface. When, however, ATIII reacts with a proteinase such as alpha-thrombin, the complex is rapidly cleared from the circulation (half-life is approximately five minutes) by a receptor present on hepatocytes. This receptor binds a number of other serine proteinase inhibitors that are members of the class designated as the "serpins." ATIII, alpha 1-proteinase inhibitor, heparin cofactor II, and alpha 1-antichymotrypsin proteinase complexes bind to the same hepatic receptor, now designated as serpin receptor 1. Proteinase complexes with alpha 2-antiplasmin, another member of the serpin class, do not bind to serpin receptor 1. Recent studies suggest that the specificity of the receptor for serpins may reside in the so-called D helix (nomenclature based on the structure of alpha 1-proteinase inhibitor). The presence of ATIII on the surface of endothelial cells offers a unique mechanism for regulating proteinases formed during coagulation. Since this ATIII is probably associated with heparin-like substances and exists in a high-affinity state, the inhibitor rapidly binds proteinases such as alpha-thrombin. Once the complex forms, its affinity for heparinoids is decreased compared with ATIII, allowing the complex to dissociate from the endothelial surface for rapid clearance by the liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552799     DOI: 10.1016/0002-9343(89)80524-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Mechanisms by Which LRP1 (Low-Density Lipoprotein Receptor-Related Protein-1) Maintains Arterial Integrity.

Authors:  Steven L Gonias
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

2.  Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.

Authors:  Katherine L Meyer-Siegler; Jacob Cox; Lin Leng; Richard Bucala; Pedro L Vera
Journal:  Cancer Lett       Date:  2009-09-16       Impact factor: 8.679

3.  Mass Spectrometry Reveals a Multifaceted Role of Glycosaminoglycan Chains in Factor Xa Inactivation by Antithrombin.

Authors:  Burcu B Minsky; Rinat R Abzalimov; Chendi Niu; Yunlong Zhao; Zachary Kirsch; Paul L Dubin; Sergey N Savinov; Igor A Kaltashov
Journal:  Biochemistry       Date:  2018-07-25       Impact factor: 3.162

4.  Effects of anticoagulation on markers of activation of clotting following major orthopedic surgery.

Authors:  M M Bern; D Hazel; D T Reilly; D M Adcock; L Hou
Journal:  Int J Lab Hematol       Date:  2015-05-15       Impact factor: 2.877

5.  Changes in concentrations of haemostatic and inflammatory biomarkers in synovial fluid after intra-articular injection of lipopolysaccharide in horses.

Authors:  Stine Mandrup Andreassen; Anne Mette Lindberg Vinther; Søren Saxmose Nielsen; Pia Haubro Andersen; Aziz Tnibar; Annemarie T Kristensen; Stine Jacobsen
Journal:  BMC Vet Res       Date:  2017-06-19       Impact factor: 2.741

6.  Inhibition of HCV by the serpin antithrombin III.

Authors:  Mohammed Asmal; Michael Seaman; Wenyu Lin; Raymond T Chung; Norman L Letvin; Ralf Geiben-Lynn
Journal:  Virol J       Date:  2012-10-02       Impact factor: 4.099

Review 7.  Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis.

Authors:  Christian J Wiedermann
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.